Skip to content

Needle Free Assessment of Myocardial Oxygenation in Healthy Subjects

A Prospective Pilot Study to Evaluate the Safety, Tolerability and Efficacy of Utilizing Precise Computer Controlled Gas Challenge in Healthy Subjects for Identification of Coronary Artery Disease

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06000540
Acronym
NIMO-Healthy
Enrollment
80
Registered
2023-08-21
Start date
2026-08-01
Completion date
2027-08-30
Last updated
2026-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

This is a prospective pilot study to evaluate the safety, tolerability and efficacy of utilizing precise computer controlled gas challenge in healthy subjects for identification of coronary artery disease.

Detailed description

This study will establish the safe and tolerable level of high PC02 and low P02 for future studies as potential stressors for coronary artery disease assessment.

Interventions

DEVICERespirAct

RespirAct device-based computer-controlled gas delivery at different concentrations as per protocol

Sponsors

Indiana University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Adults ≥ 45 years of age 2. No known cardiac disease

Exclusion criteria

1. Low blood pressure (systolic blood pressure \< 100 mmHg) 2. Inability to voluntarily increase their breathing rate if prompted to do so 3. Persons with the inability to lie supine for 30-40 minutes 4. Persons who are pregnant, nursing, or implanted with intrauterine devices (IUD's) 5. Persons with significant neurological, pulmonary, renal or hepatic disease 6. Persons who have an abnormal cardiac rhythm or resting heart rate \>100/min 7. Inability or unwillingness to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Physiological Parameters Monitoring3 hours1. Saturation of peripheral oxygen as percentage 2. Heart rate as beats per minute 3. Noninvasive blood pressure as mmHg 4. Partial pressure of oxygen as mmHg 5. Partial pressure of carbon dioxide as mmHg
Assessment of Symptom Severity and Incidence3 hours1. Chest pain 2. Headache 3. Dizziness 4. Confusion 5. Fatigue 6. Upset stomach 7. Nausea 8. Vomiting

Secondary

MeasureTime frameDescription
Participant CompletionDay 1 and Day 2Procedure tolerability will be evaluated by the number of participants completing day 1 and day 2 of study participation.
Patient comfort level score3 hoursParticipants will be asked to rate their comfort level for breathing from the mask and the gas changes as Painful, Not Comfortable, Tolerable for short time, tolerable for entire study, or comfortable.
Quality of Cardiac MRI3 hoursThe cardiac MRI images will be assessed for quality.

Countries

United States

Contacts

CONTACTClinical Research Coordinator
csaha@iu.edu317 274 0975

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 21, 2026